Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REPROS THERAPEUTICS INC. (RPRX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Sep-30-17 | Jun-30-17 | Mar-31-17 | Dec-31-16 | Sep-30-16 | Jun-30-16 | Mar-31-16 | Dec-31-15 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 49.4% | 533.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 50.6% | -433.3% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 2084.9% | 29860.0% | 29107.9% | 26566.7% | 30058.0% | 42324.4% | 76148.1% | 219236.4% |
| General and administrative | 2195.1% | 23896.7% | 19250.0% | 9516.7% | 9170.0% | 11434.1% | 18437.0% | 46245.5% |
| Depreciation | 1.2% | 13.3% | 10.5% | 10.4% | 14.0% | 24.4% | 59.3% | 218.2% |
| EBIT | -4097.8% | -53756.7% | -48357.9% | -36083.3% | -39228.0% | -53758.5% | -94585.2% | -265481.8% |
| Pre-tax income | -4229.3% | -54190.0% | -48257.9% | -35983.3% | -39128.0% | -53658.5% | -94485.2% | -265381.8% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -4229.3% | -54190.0% | -48257.9% | -35983.3% | -39128.0% | -53658.5% | -94485.2% | -265381.8% |
|